News
- Category: News
- The faces behind the CARE work-packages – WP6
- The faces behind the CARE work-packages – WP5
- The faces behind the CARE work-packages – WP4
- Published in eBioMedicine: Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
- Published in JAMA Oncology: Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
- Published in MDPI: Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication
- Published in CellPress iScience: Computed Tomography and [18 F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates
- CARE 2nd Annual meeting
- CARE paper published in Antiviral Research: Insight on the activity of Remdesivir, Molnupiravir and Nirmatrelvir on SARS-CoV-2 variants of concern
- CARE paper published in Journal of Medical Virology: Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity
- White paper published: High throughput cryo-electron microscopy epitope mapping of SARS-CoV-2 spike protein antibodies
- Published in Nature Communications: Mechanism of AT-527 presents as a promising research avenue against COVID-19
- The faces behind the CARE work-packages – WP3
- The faces behind the CARE work-packages – WP2
- The faces behind the CARE work-packages – WP1
- CARE paper published in JCIM: Modeling of protein-small molecule complexes with HADDOCK
- CARE paper published in Journal of Virology: New insights for assessment of SARS-CoV-2 infection estimates and (vaccine-induced) antibody durability response
- CARE paper published in Science Translational Medicine: New cell-free assay
- CARE paper published in Circulation: Mechanisms of SARS-CoV-2 with regards to endothelial cells
- CARE paper published in iScience: CD177 is associated with coronavirus disease 2019 severity and death
- CARE paper published in Nature: HCQ use against SARS-CoV-2 infection
- Repurposing efforts concluded
- CARE scientists identified a SARS-CoV-2 neutralizing antibody with activity against all known variants of concern
- One Year of CARE Against COVID-19
- One Year of CARE Against COVID-19
- One Year of CARE Against COVID-19
- Survey on GDPR and eConsent during the COVID-19 pandemic
- Mention of CARE in Le Monde
- EMA – ITF collaboration
- IMI Press release
- CARE Press release
- CARE Kick-off meeting week
- Start of the CARE project